Bernstein Lifts Ratings on Cigna and CVS, Citing PBM Reform as Catalyst
Bernstein upgraded Cigna Group and CVS Health to Outperform, raising price targets and nudging valuation multiples higher after concluding that recent pharmacy benefit manager (PBM) reforms have removed a major uncertainty for the sector. Analyst Lance Wilkes pointed to new PBM transparency legislation, an FTC settlement and company-level PBM model…